Compare Manhattan Associates Inc (MANH) vs UiPath Inc (PATH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs UiPath Inc — how do they compare? Manhattan Associates Inc trades at $204.89 (market cap $12.06B), while UiPath Inc trades at $13.48 (market cap $6.91B). The key difference: Manhattan Associates Inc is the larger of the two by market cap, and Manhattan Associates Inc is trading nearer its 52-week high, UiPath Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Manhattan Associates Inc for 12 Days and UiPath Inc for 139 Days on average.
| MANH | PATH | |
|---|---|---|
Market Cap | $12.06B | $6.91B |
Volume | 376,150 | 34,321,250 |
Sector | Technology | Technology |
52-Week High | $223.76 | $19.29 |
52-Week Low | $120.88 | $9.38 |
Typical Hold Time | 12 Days | 139 Days |
Enterprise Value | $11.93B | $5.70B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MANH trades at $204.89, up 1.38% on the day, with a bullish technical trend and strong profitability metrics including a 96.38% ROE and 18.67% net income margin. The stock has consistently beaten earnings estimates in recent quarters, though high valuation ratios like a P/E of 59.26 suggest premium pricing. Recent news includes a mix of positive product launches and ongoing legal investigations into fiduciary duties.
The outlook is cautiously optimistic, supported by analyst consensus and solid fundamentals, but risks include the high valuation, potential legal overhangs, and a projected decline in net income for 2026. Upside potential exists toward the $210.50 consensus target if execution remains strong.
UiPath (PATH) trades at $13.25, up 1.38% today, with a bullish technical signal from moving averages despite neutral oscillators. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to projected $1.7B in 2026, while narrowing net losses from -$74M to projected $362M profit. Recent partnerships with Snowflake and BDO highlight strategic expansion in AI orchestration capabilities.
PATH offers compelling value at current levels with 14% upside to consensus price target of $15.13. Strong enterprise AI adoption and improved profitability outlook support growth, though execution risks and competitive pressures in automation software warrant monitoring. The stock presents a balanced risk-reward profile for investors seeking automation exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →
